Hepatitis A vaccination effectiveness during an outbreak in the Ukraine

Vaccine

Volumn 26, Issue 25, 2008, Pages 3135-3137

  Selnikova, Olga ^a   Moisseeva, Anna ^a   Zadorozhnaja, Viktoria ^b   Dokachenko, Anatoliy ^b   Kachur, Nadejda ^b   Gavrik, Spartak ^b  

^a Ministry of Health of Ukraine   (Ukraine)

^b Lugansk Sanitary and Epidemiological Station   (Ukraine)

Author keywords

Children; Effectiveness; Hepatitis A; Outbreak; Vaccination

Indexed keywords

HEPATITIS A VACCINE; INACTIVATED VIRUS VACCINE; VIRUS ANTIBODY;

ANTIBODY RESPONSE; CHILD; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; EVALUATION; HEPATITIS A; HEPATITIS A VIRUS; HUMAN; IMMUNIZATION; INCIDENCE; LETTER; PRIORITY JOURNAL; SEROLOGY; SINGLE DRUG DOSE; UKRAINE; VACCINATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; HEPATITIS A; HEPATITIS A VACCINES; HUMANS; UKRAINE; VACCINATION;

EID: 44749086435     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.11.016     Document Type: Letter

References (12)

1. Bell B.P. Hepatitis A vaccine. Semin Pediatr Infect Dis 13 (2002) 165-173
2. Black S., Shinefield H., Hansen J., Lewis E., Su L., and Coplan P. A post-licensure evaluation of the safety of inactivated hepatitis A vaccine (VAQTA Merck) in children and adults. Vaccine 22 (2004) 766-772
3. Van Damme P., Banatvala J., Fay O., Iwarson S., McMahon B., Van Herck K., et al. Hepatitis A booster vaccination: is there a need?. Lancet 362 (2003) 1065-1071
4. Bovier P.A., Bock J., Loutan L., Farinelli T., Glueck R., and Herzog C. Long-term immunogenicity of an inactivated virosome hepatitis A vaccine. J Med Virol 68 (2002) 489-493
5. Van Herck K., and Van Damme P. Inactivated hepatitis A vaccine-induced antibodies: follow-up and estimates of long-term persistence. J Med Virol 63 (2001) 1-7
6. Van Damme P., and Van Herck K. Effect of hepatitis A vaccination programs. JAMA 294 (2005) 246-248
7. Bonanni P., Franzin A., Staderini C., Pitta M., Garofalo G., Cecconi R., et al. Vaccination against hepatitis A during outbreaks starting in schools: what can we learn from experiences in central Italy?. Vaccine 23 (2005) 2176-2180
8. D'Argenio P., Adamo B., Cirrincione R., and Gallo G. The role of vaccine in controlling hepatitis A epidemics. Vaccine 21 (2003) 2246-2249
9. McMahon B.J., Beller M., Williams J., Schloss M., Tanttila H., and Bulkow L. A program to control an outbreak of hepatitis A in Alaska by using an inactivated hepatitis A vaccine. Arch Pediatr Adolesc Med 150 (1996) 733-739
10. Victor J.C., Monto A.S., Surdina T.Y., Suleimenova S.Z., Vaughan G., Nainan O.V., et al. Hepatitis A vaccine versus immune globulin for postexposure prophylaxis. N Engl J Med 357 (2007) 1685-1694
11. Averhoff F., Shapiro C.N., Bell B.P., Hyams I., Burd L., Deladisma A., et al. Control of hepatitis A through routine vaccination of children. JAMA 286 (2001) 2968-2973
12. Dagan R., Leventhal A., Anis E., Slater P., Ashur Y., and Shouval D. Incidence of hepatitis A in Israel following universal immunization of toddlers. JAMA 294 (2005) 202-210